Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Other Non Operating Income (2021 - 2024)

Eton Pharmaceuticals (ETON) has disclosed Other Non Operating Income for 3 consecutive years, with $169000.0 as the latest value for Q4 2024.

  • Quarterly Other Non Operating Income rose 121.13% to $169000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $169000.0 through Dec 2024, changed N/A year-over-year, with the annual reading at $389000.0 for FY2025, 130.18% up from the prior year.
  • Other Non Operating Income hit $169000.0 in Q4 2024 for Eton Pharmaceuticals, up from -$800000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $800000.0 in Q2 2023 to a low of -$800000.0 in Q4 2023.
  • Historically, Other Non Operating Income has averaged $133500.0 across 3 years, with a median of $267000.0 in 2021.
  • Biggest YoY gain for Other Non Operating Income was 121.13% in 2024; the steepest drop was 121.13% in 2024.
  • Year by year, Other Non Operating Income stood at $365000.0 in 2021, then crashed by 319.18% to -$800000.0 in 2023, then soared by 121.12% to $169000.0 in 2024.
  • Business Quant data shows Other Non Operating Income for ETON at $169000.0 in Q4 2024, -$800000.0 in Q4 2023, and $800000.0 in Q2 2023.